在急性髓性白血病治疗中,CAR-T细胞的分子标选择问题
Varvara Maiorova1, Murad D Mollaev1, Polina Vikhreva1
1Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow 117198, Russia.
International journal of molecular sciences
|June 26, 2025
概括
化学抗原受体 (CAR) -T疗法在急性髓性白血病 (AML) 中显示出前景. 本综述讨论了选择CAR AML目标的挑战,并提出了一种更有效地消除病理细胞的策略.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 血液学 血液学 血液学
背景情况:
- 化学抗原受体 (CAR) -T疗法已经彻底改变了B细胞恶性瘤治疗.
- 由于细胞异质性和抗原变异,急性髓性白血病 (AML) 对CAR-T提出了挑战.
- 确定合适的分子点对于有效的AML治疗至关重要.
研究的目的:
- 审查在AML中选择CAR结构的分子标的关键方面.
- 讨论AML相关抗原在疾病进展中的作用.
- 提出一种用于增强AML病理细胞消除的新方法.
主要方法:
- 文献综述侧重于血液性恶性瘤中CAR-T疗法.
- 分析影响AML分子标选择的因素.
- 评估AML相关抗原及其在疾病进展中的作用.
主要成果:
- 由于目标异质性,CAR-T疗法在AML中面临着障碍.
- 特定的AML相关抗原在疾病进展中发挥作用.
- 为了使CAR-T在AML中的有效性,需要采用战略方法来选择目标.
结论:
- 选择适当的分子点是开发有效的CAR-T治疗AML的关键.
- 了解AML中的抗原动态对于治疗成功至关重要.
- 拟议的方法可以改善AML的病理细胞消除.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675


